Hypotension and disseminated intravascular coagulation following intralesional bacillus Calmette-Guérin therapy for locally metastatic melanoma
- PMID: 1998973
- PMCID: PMC11037993
- DOI: 10.1007/BF01789050
Hypotension and disseminated intravascular coagulation following intralesional bacillus Calmette-Guérin therapy for locally metastatic melanoma
Abstract
Four patients developed serious hypotension and signs of disseminated intravascular coagulation shortly after a second round of Tice bacillus Calmette-Guérin (BCG) injections into locally recurrent cutaneous melanoma satellite nodules. Each of these patients survived following intensive therapy with isoniazid, pyridoxine, steroids, pressors, antibiotics, and cardio-renal support including, in one case, three acute hemodialyses. Plasma specimens from two of the four patients caused gelation of lysate from the amebocytes of Limulus polyphemus, indicating the presence of endotoxin or an endotoxin-like substance. In vitro studies on the BCG preparations led us to conclude that this endotoxin activity in the plasma is not the result of direct injection of endotoxin with the BCG preparation, but rather from release of endotoxin from endogenous sources, such as the intestinal tract during a period of relative hypotension following an allergic reaction. Prior immunity appeared to be the consistent factor in the toxic reactions reported herein. Finally, we present recommendations for serial monitoring of these patients and discuss the use of an alternative agent for intralesional therapy.
Similar articles
-
Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene.Cancer. 1978 Jun;41(6):2456-63. doi: 10.1002/1097-0142(197806)41:6<2456::aid-cncr2820410654>3.0.co;2-b. Cancer. 1978. PMID: 657108 Clinical Trial.
-
Fatal disseminated bacillus Calmette-Guerin infection and arrested growth of cutaneous malignant melanoma following intralesional immunotherapy.Am J Dermatopathol. 1986 Aug;8(4):331-5. doi: 10.1097/00000372-198608000-00010. Am J Dermatopathol. 1986. PMID: 3532854
-
Immunotherapy of melanoma with BCG: two fatalities following intralesional injection.Cancer. 1975 Feb;35(2):514-20. doi: 10.1002/1097-0142(197502)35:2<514::aid-cncr2820350233>3.0.co;2-f. Cancer. 1975. PMID: 234291
-
Clinical and molecular insights into BCG immunotherapy for melanoma.J Intern Med. 2020 Dec;288(6):625-640. doi: 10.1111/joim.13037. Epub 2020 Mar 4. J Intern Med. 2020. PMID: 32128919 Review.
-
Disseminated Bacillus Calmette-Guérin (BCG) infection with pulmonary and renal involvement: A rare complication of BCG immunotherapy. A case report and narrative review.Pulmonology. 2020 Nov-Dec;26(6):346-352. doi: 10.1016/j.pulmoe.2019.10.001. Epub 2019 Nov 9. Pulmonology. 2020. PMID: 31711964 Review.
Cited by
-
Keyhole limpet hemocyanin immunotherapy of murine bladder cancer.Urol Res. 1993 Jan;21(1):33-7. doi: 10.1007/BF00295189. Urol Res. 1993. PMID: 8456536
-
Intralesional injection of rose bengal induces a systemic tumor-specific immune response in murine models of melanoma and breast cancer.PLoS One. 2013 Jul 17;8(7):e68561. doi: 10.1371/journal.pone.0068561. Print 2013. PLoS One. 2013. PMID: 23874673 Free PMC article.
-
Intralesional Immunotherapy for Metastatic Melanoma: The Oldest and Newest Treatment in Oncology.Crit Rev Oncog. 2016;21(1-2):65-73. doi: 10.1615/CritRevOncog.2016017124. Crit Rev Oncog. 2016. PMID: 27481003 Free PMC article. Review.
-
Developments in Intralesional Therapy for Metastatic Melanoma.Cancer Control. 2016 Jan;23(1):12-20. doi: 10.1177/107327481602300104. Cancer Control. 2016. PMID: 27009452 Free PMC article. Review.
-
Topical and Intralesional Treatments for Skin Metastases and Locoregionally Advanced Melanoma.Cancers (Basel). 2024 Dec 29;17(1):67. doi: 10.3390/cancers17010067. Cancers (Basel). 2024. PMID: 39796696 Free PMC article. Review.
References
-
- Briggs PC, Heckler F. Axillary lymphadenopathy: complication of BCG immunotherapy for melanoma. Plast Reconstr Surg. 1988;81:952–953. - PubMed
-
- Clark WH, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanoma of the skin. Cancer Res. 1969;29:705–726. - PubMed
-
- Clark WH, Ainsworth AM, Bernardino EA, Yang CH, Mihm MC. The developmental biology of primary human malignant melanomas. Semin Oncol. 1975;2:83–103. - PubMed
-
- Caridis DT, Reinhold RB, Woodruff PWH, Fine J. Endotoxaemia in man. Lancet. 1972;1:1381–1386. - PubMed
-
- Cohen SG, Benaceraf B, McClusky RT, Ovary Z. Effect of anticoagulants on delayed hypersensitivity reactions. J Immunol. 1967;98:351. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical